TWST Trading Analysis - 11/02/2026 01:59 PM — TRU-SENTIMENT

News Headlines & Context

Twist Bioscience (TWST) has seen elevated volatility tied to its position as a synthetic DNA platform player. Recent general-knowledge context includes:

• Biotech sector rotation and funding concerns have pressured speculative names with negative EPS like TWST through late 2026.
• Twist reported fiscal year end 2026 on Sept 1, 2026 per fundamentals; no positive earnings cited, with trailing EPS of -2.23.
• High beta (2.48) and historical volatility (111.78%) suggest sensitivity to broad market de-risking events.
• No specific verified TWST earnings date beyond fiscal year-end was retrieved; however, option chain shows major Dec 18, 2026 expiration, implying potential year-end catalyst focus.
• Headlines context: Negative profitability and extreme vol likely feed the bearish options positioning seen in embedded data, even as daily chart shows uneven recovery attempts from October lows.

This news context is separated from the strict data analysis below, which uses only embedded JSON.

Fundamental Analysis

Based strictly on provided FUNDAMENTALS data:

• Trailing EPS is -2.23; company is not profitable (no positive earnings trend in data).
• Trailing PE: null; Forward PE: null; PEG: null — valuation via earnings multiples not available.
• Profit margins, ROE, revenue growth, debt/equity, free cash flow: all null in data.
• Market cap: $8,789,523,570.00; shares out: 66,301,000.00; institutional hold: 99.70%.
• Dividend yield 0.0%; beta 2.48; 52-wk high 219.71, low 23.30.
• Historical volatility 111.78%; avg volume 2,997,000.00.
• Analyst target mean: null; recommendation key: null — no street consensus in data.

Fundamentals show a high-institution-owned, unprofitable, high-beta small-cap. This diverges from any bullish technical read and aligns with bearish options sentiment.

Current Market Position

From minute bars (2026-10-30 to 2026-11-02 13:30): first bar close 160.89, last bar close 132.40 — decline of ~17.7% across window. Daily history shows 2026-10-30 close 154.26 (indicators current price). Intraday 2026-11-02 13:10–13:30 closed 133.34 down to 132.40 on low volume (<20k/min).

Minute bars show persistent lower closes; weak intraday momentum into Nov 2.

Technical Analysis

SMA5 (161.44) > SMA20 (154.39) > SMA50 (153.32): mild bullish alignment on daily, but price (154.26) sits just under SMA20. RSI 51.39 = neutral. MACD positive histogram = slight bullish bias. Bollinger mid = 154.39, price near mid; bands wide (121–187) = high vol. 30d range high 219.71, low 130.68; price near lower third.

True Sentiment Analysis (Delta 40-60 Options)

From embedded options JSON (2026-11-02 13:58):

Call Volume: $59,970.00 (2.80%) Put Volume: $2,097,330.00 (97.20%) Total: $2,157,300.00

Sentiment: Bearish. Put contracts 362 vs call 38. Pure directional conviction heavily put-weighted. Divergence: technicals neutral/mild bullish, sentiment strongly bearish. Spread engine flagged divergence, no recommendation.

Key Price Levels (Observational Only)